Author: Hanson, Kimberly E.; Couturier, Marc Roger
Title: Multiplexed Molecular Diagnostics for Respiratory, Gastrointestinal, and Central Nervous System Infections Cord-id: h3flp86l Document date: 2016_7_20
ID: h3flp86l
Snippet: The development and implementation of highly multiplexed molecular diagnostic tests have allowed clinical microbiology laboratories to more rapidly and sensitively detect a variety of pathogens directly in clinical specimens. Current US Food and Drug Administration–approved multiplex panels target multiple different organisms simultaneously and can identify the most common pathogens implicated in respiratory viral, gastrointestinal, or central nervous system infections. This review summarizes
Document: The development and implementation of highly multiplexed molecular diagnostic tests have allowed clinical microbiology laboratories to more rapidly and sensitively detect a variety of pathogens directly in clinical specimens. Current US Food and Drug Administration–approved multiplex panels target multiple different organisms simultaneously and can identify the most common pathogens implicated in respiratory viral, gastrointestinal, or central nervous system infections. This review summarizes the test characteristics of available assays, highlights the advantages and limitations of multiplex technology for infectious diseases, and discusses potential utilization of these new tests in clinical practice.
Search related documents:
Co phrase search for related documents- acid sequencing and low prevalence: 1
- actionable diagnosis and acute diagnosis: 1, 2
- acute diagnosis and low prevalence: 1, 2, 3, 4, 5
- acute diagnosis and low respiratory tract: 1
- acute diarrhea and low prevalence: 1
- acute diarrhea and low respiratory tract: 1
- additional testing and low prevalence: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date